By integrating single-nucleus transcriptomics, spatial multi-omics, and proteomics in human liver samples, we delineate the evolving landscape of hepatic macrophages across the MASLD spectrum. Attached presentation include representative images of standard immunohistochemistry (DAB) on liver samples from at-risk MASH patients showing the expression of macrophage markers used in immunofluorescence multiplexing.